You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

237 Items

Radionuclide Therapy for Patients with Neuroendocrine Tumors (NETs) in Ontario: Expert Panel Report

Document Status: Current
ID: GL-C50-01

Jan 2011

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Document Status: Current
ID: GL-C50-21

Jul 2015

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Document Status: Current

Apr 2018

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Document Status: Current

Apr 2021

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Document Status: Current
ID: GL-C50-30

Feb 2017

Referral of Patients with Suspected Colorectal Cancer by Family Physicians and Other Primary Care Providers

Document Status: Current
ID: 24-1
Version: 2

Apr 2017

Referral of Suspected Lung Cancer by Primary Care Practitioners

Document Status: Current
ID: 24-2
Version: 2

Jan 2019

Referral of Suspected Prostate Cancer by Family Physicians and Other Primary Care Providers

Document Status: Current
ID: 24-3
Version: 2

Dec 2016

Regional Models of Care for Systemic Treatment: Standards for the Organization and Delivery of Systemic Treatment

Document Status: Current
ID: GL 12-10
Version: 2

Jul 2019

Regional Therapies for Colorectal Cancer Liver Metastases

Document Status: Current
ID: GL 2-30a
Version: N/A

Mar 2020

Risk Reduction Strategies for BRCA1/2 Hereditary Ovarian Cancer Syndromes

Document Status: Current
ID: GL #4-4v2
Version: 2

Sep 2020

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Document Status: Current
ID: GL 2-33
Version: 2

Updated

Jun 2025